INTRODUCTION
Transurethral treatments for benign prostatic hyperplasia (BPH), with transurethral resection of the prostate (TURP) as the most representative procedure, have rapidly evolved in recent years with the advent of various novel surgical devices and techniques. Alongside this progress, a gradual increase in postoperative urethral stricture (US) cases has been observed.[1] The reported incidence of US following such procedures ranges from 2.2% to 9.8%, with common sites including the meatus, the penoscrotal junction, and the proximal bulbar urethra.[2345] A recent meta-analysis indicates that the pooled incidence of US was 1.7% after enucleation, 2.1% after ablation, 3.8% after monopolar (M)-TURP, and 2.1% after bipolar (B)-TURP.[6] Urethroplasty has garnered attention in recent years as a definitive treatment for US. However, proximal bulbar USs (PBUS) that occur after BPH surgery (post-TURP PBUS) remain a particularly challenging subset for reconstructive urologists.
This is largely due to concerns regarding potential adverse effects on urinary continence. As is well recognized, urinary continence is maintained by a dual mechanism involving the autonomic internal urethral sphincter and the somatic external urethral sphincter. While procedures such as TURP inherently involve resection of the internal sphincter, continence is generally preserved due to the residual function of the external sphincter.
Nevertheless, urethroplasty involving the proximal bulbar or membranous urethra may require dissection near the external sphincter, potentially compromising the remaining continence mechanism. Despite this concern, few studies have directly investigated the impact of such procedures on postoperative continence. In this study, we aimed to retrospectively evaluate the outcomes of urethroplasty for post-TURP PBUS, focusing particularly on its effect on urinary continence, quality of life (QoL), and surgical satisfaction using data from reconstructive centers in Japan.
The primary outcome was the impact of urethroplasty on continence (change in ICIQ-SF), and the secondary outcomes were overall QoL and patient satisfaction.
METHODS
The ethics committees of the two institutions involved in this research approved the study. The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients for their data to be used for research purposes.
Patients
A minimum 3-month period of urethral rest was ensured before evaluation by retrograde urethrography (RUG) and voiding cystourethrography (VCUG), during which no transurethral instrumentation or manipulation was performed. When necessary (e.g., urinary retention), a suprapubic catheter was placed to maintain bladder drainage.
Based on their clinical history and imaging findings, strictures were classified according to the LSE (Length–Segment–Etiology) classification system, which categorizes strictures by length (L), segment or location (S), and etiology (E).[7] Patients who underwent urethroplasty for post-TURP PBUS at our institutions between November 2013 and August 2024 were retrospectively reviewed. Only patients with complete pre- and postoperative data from the patient-reported outcome measure (PROM) for US surgery[89] and the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-SF), as well as postoperative cystoscopic findings, were included in the analysis.
Data collection
Patient data, including age, height, weight, type of BPH surgery, type of urethroplasty, disease duration, operative time, estimated blood loss, presence or absence of corporal splitting, urinary retention, and history of transurethral procedure, were collected through a review of medical records. The history of transurethral procedure refers to whether patients had undergone any prior transurethral treatment involving urethral dilation or manipulation for their post-TURP strictures before urethroplasty.
Patients were grouped according to worsening continence (WC) status. Disease duration was defined as the interval between the diagnosis of US and urethroplasty.
Surgical technique
All urethroplasties were conducted under general anesthesia, using a perineal approach with the patient in the lithotomy position. A total of 12 surgeons performed the procedures, all under the direct supervision of experienced reconstructive urologists (T.T. and H.A.), each with experience in more than 100 urethroplasties. The details of the surgical technique have been previously described elsewhere.[10] In short, when a tension-free anastomosis was deemed achievable, anastomotic urethroplasty – either excision and primary anastomosis (EPA)[1112] or nontransecting anastomotic urethroplasty (NTAU)[13] – was the preferred option.
Prior to 2020, all eligible cases were managed with EPA. Since 2020, however, NTAU has been preferentially employed in cases presenting with minimal fibrosis. If the stricture was longer than 2 cm, dorsal onlay augmentation urethroplasty using oral mucosa was performed.
The final decision between anastomotic urethroplasty and substitution urethroplasty was determined by assessing the feasibility of tension-free anastomosis between the intended sites of anastomosis. This evaluation occurred after sufficient urethral mobilization and, if necessary, following separation of the corpus cavernosum.
Patient follow-up and definition of outcomes
All patients were followed up at 3, 6, and 12 months postoperatively and then annually. At each visit, uroflowmetry and postvoid residual measurement were performed, together with completion of the PROM and ICIQ-SF questionnaires. A 17-Fr flexible cystoscope (CYF-VHA, Olympus, Tokyo, Japan) was routinely used at 6 months postoperatively or earlier if restricture was suspected based on decreased flow or worsening lower urinary tract symptoms.
In this study, stricture-free (SF) status was defined as the smooth passage of a cystoscope. WC was defined as an increase in the ICIQ-SF total score at 6 months postoperatively compared to the preoperative score. Social pad-free status was defined as the use of one or fewer pads per day.
Statistical analysis
For all statistical analyses, P < 0.05 was considered statistically significant. Continuous variables are presented as medians with interquartile ranges, and categorical variables are presented as numbers and percentages. Comparisons between patients with and without WC were performed using the Mann–Whitney U-test for continuous variables and the Chi-square test for categorical variables.
Changes in ICIQ-SF total scores and QoL scores between the preoperative and postoperative periods were assessed using the Wilcoxon signed-rank test. The database was constructed using Microsoft Excel (Redmond, WA, USA), and statistical analyses were conducted with R software (version 4.1.2) (R Foundation for Statistical Computing; Vienna, Austria).
The authors confirm the availability of, and access to, all original data reported in this study.
RESULTS
Surgical outcome
All patients who underwent urethroplasty for post-BPH surgery PBUS had complete data required for the analysis, and none were excluded due to missing information or loss to follow-up. The median follow-up duration was 49 months. A total of 34 patients were included in this analysis.
Of these, 32 (94%) achieved an SF status. Of the two patients who experienced stricture recurrence, one treated with NTAU underwent transurethral dilation, while the other treated with EPA was managed conservatively without further intervention.
WC was observed in 5 patients (14%; 95% confidence interval [CI]: 5–31), and 33 patients (97%; 95% CI: 84–100) remained socially pad-free. When stratified by surgical technique, WC occurred in 2 of 13 (15%) patients after EPA and 2 of 20 (10%) patients after NTAU, showing no apparent difference in continence outcomes. The pseudomedian difference in ICIQ-SF total scores was 2.75 (95% CI: −1.5–5.0; P = 0.15, Wilcoxon signed-rank test), while the pseudomedian difference in QoL scores was 1.75 (95% CI: 1.0–2.0; P < 0.01, Wilcoxon signed-rank test) [Figure 1].
The greatest improvements occurred in voiding-related domains (pseudomedian difference = 6.5, 95% CI: 4.5–9.0; P < 0.01).
Comparison between patients with and without worsening continence
Patients were categorized into two groups: WC(+) for those with worsened continence and WC(−) for those without. Table 1 summarizes the patient characteristics according to WC status. No statistically significant differences were observed between the WC(+) and WC(−) groups with respect to age, stricture length, disease duration, estimated blood loss, height, body mass index, type of BPH surgery or urethroplasty, presence or absence of corporal splitting, urinary retention, or history of transurethral procedures for US.
Unfortunately, detailed information regarding the exact type of endoscopic intervention (e.g., direct visual internal urethrotomy, laser incision, bougie dilation, or balloon dilation) was not available.
Table 2 shows the number of patients with worsened QoL scores and the distribution of surgical satisfaction, categorized according to both WC and SF status. Notably, in the WC(+) group, no patients reported worsened QoL or dissatisfaction with the surgical outcome.
DISCUSSION
In this study, postoperative deterioration in urinary continence was observed in 5 out of 34 (14%) patients. However, a comparison of pre- and postoperative ICIQ-SF total scores among all 34 patients revealed no statistically significant difference. Thirty-two (94%) patients achieved an SF status, and an overall improvement in QoL was noted.
Interestingly, none of the five patients who experienced worsening ICIQ-SF scores reported a decline in their QoL scores, and their overall satisfaction with surgery remained favorable.
Post-TURP PBUS is not an uncommon complication. However, the optimal surgical approach for this condition has yet to be clearly defined. Figure 2 shows the representative RUG and VCUG images of post-TURP PBUS.
The bladder neck appears dilated, and it is readily apparent that the external urethral sphincter plays a crucial role in maintaining continence. The external urethral sphincter has an omega-shaped configuration and lacks ventral fibers. Based on this anatomical consideration, Kulkarni et al. advocated the use of a ventral onlay approach to preserve continence in such cases.[14] Barbagli et al. reported that among 69 patients with post-TURP PBUS treated with a ventral onlay technique, 58 achieved an SF outcome, although 3 patients developed urinary incontinence.[15] In cases of complete obstruction, some authors have utilized double-face urethroplasty.
Despite involving a dorsal approach, this technique minimizes disruption of dorsal sphincteric fibers due to the inlay nature of the graft. Notably, no cases of worsened continence were reported in that series.[16] Gómez et al. reported that continence was preserved in 85% of cases when the stricture was managed through an intrasphincteric approach.[17] While many of these strategies aim to avoid injury to the dorsal component of the external sphincter, a multi-institutional study by Angulo et al. showed that even dorsal onlay urethroplasty did not significantly compromise continence.[18] Thus, the precise impact of surgical approach on continence preservation remains uncertain. Table 3 provides a summary of surgical outcomes from previous studies focusing on post-TURP PBUS.
In our cohort, 13 patients underwent EPA, 20 underwent NTAU, and 1 patient underwent dorsal onlay. Overall, only 14% experienced any worsening of continence. Notably, we adopted a relatively stringent definition of continence deterioration, in which any worsening of the ICIQ-SF score – rather than merely increased pad usage – was considered deterioration.
By this strict definition, only one patient (2.9%) required more than a safety pad. In our institutions, careful dissection is performed to preserve the dorsal continuity of the urethra while mobilizing it from the surrounding tissue. The urethrotomy on the proximal side of the stricture is limited to the urethral mucosa only, and once normal mucosa is identified, the apical portion of the healthy mucosa at the 12 o’clock position is sutured to the surrounding tissue.
This approach avoids full-thickness incision while ensuring a sufficient anastomotic caliber, which we believe results in an “intrasphincteric” dissection in practice. It is also noteworthy that even among patients with worsened ICIQ-SF scores, QoL and satisfaction scores remained high. While detailed questionnaires can detect subtle changes in continence, the practical impact on daily life appears minimal, and most patients likely experienced a net improvement in voiding function due to the resolution of the stricture.
These findings also suggest that relief from stricture may have a greater impact on QoL and patient satisfaction than continence status. To our knowledge, no previous studies have assessed changes in continence and postoperative QoL with patient satisfaction in this specific patient population. In this regard, the present study provides valuable and novel data.
Due to concerns regarding urethral blood supply following EPA, we currently prioritize NTAU as the first-line technique.[20] Both approaches appear to have minimal impact on continence and can be performed safely. However, if urinary incontinence later requires placement of an artificial urinary sphincter (AUS), the differences between NTAU and EPA may become clinically important. It has been reported that urethral erosion after AUS placement occurs at a nearly threefold higher rate in patients with prior urethroplasty.[21] Procedures that better preserve vascularity, such as NTAU, may thus be advantageous in reducing such complications.
This study has several limitations. First, it is a retrospective analysis based on a relatively small sample size, and various biases – such as selection bias – may have been present. In Japan, only a limited number of institutions perform urethroplasty.
Consequently, patients must often travel long distances to undergo surgery, meaning that only those with sufficient functional status are selected for treatment. Therefore, our cohort may represent a subset of healthier or more motivated patients among those with post-TURP PBUS.
Furthermore, most prior BPH procedures in this cohort were TURP or Holmium laser enucleation of the prostate (HoLEP). Whether these findings are applicable to strictures following newer, minimally invasive techniques remains unclear. Due to the low number of patients with continence deterioration in this study, we were unable to identify specific risk factors for this outcome.
The present study’s small sample size may be insufficient to ensure full statistical validity. In addition, no multivariate analysis was performed due to the limited number of events, and long-term (>2 years) continence outcomes were not systematically assessed. Nonetheless, we believe that these findings provide a valuable foundation for future confirmatory research.
Second, although proximity to the membranous urethra might theoretically increase the risk, defining the exact anatomical boundary between the bulbar and membranous urethra is challenging both preoperatively (through urethrography) and intraoperatively. In addition, it should be noted that BPH surgeries alone can cause incontinence in a small percentage of patients – reported as 1%–5% for TURP and 2.2%–7.1% for HoLEP.[22] Therefore, it is conceivable that in some cases, latent incontinence becomes unmasked only after successful stricture repair. Surgeons should thus carefully evaluate continence status not only preoperatively, but also shortly after the original BPH surgery, and ensure thorough patient counseling prior to urethroplasty.
CONCLUSIONS
Urethroplasty for PBUS following BPH surgery appears to have minimal adverse impact on urinary continence while effectively improving voiding function and patient QoL. These findings support the procedure as a safe and valuable option in this challenging subset, although continued surveillance and further research are warranted.
Conflicts of interest
There are no conflicts of interest.